Because peptides are specific in their action, they generally do not cause the widespread side effects associated with many pharmaceuticals
(2007) investigated tesamorelin in a randomized clinical trial and demonstrated its ability to stimulate endogenous GH secretion and modulate visceral adipose tissue parameters, establishing the clinical profile of this blend component [1]
Recently, an increase in BDNF synthesis has been demonstrated in a pentylenetetrazol (PTZ) kindling model of epilepsy, after chronic treatment with liraglutide in combination with antiepileptic drug, levetiracetam, which also exerted antidepressive effects, e.g
GLP-14 GLP-1GLP-1 GLP-14 11 11 1 11 0.6mg 0.3mg , et al
Research-grade versions of CJC-1295 and Ipamorelin are not intended for human use and lack the purity and quality controls of medical-grade peptides